Related Experiment Videos
Central nervous system toxicity from nebulized atropine sulfate
Z J Herschman1, J Silverstein, G Blumberg
1Mount Sinai School of Medicine, Elmhurst Hospital Center, New York.
Journal of Toxicology. Clinical Toxicology
|January 1, 1991
Summary
Central anticholinergic syndrome can occur from medical treatments. A patient developed this condition after receiving aerosolized atropine, highlighting a potential iatrogenic risk.
Area of Science:
- Pharmacology
- Toxicology
- Internal Medicine
Background:
- Central anticholinergic syndrome is a serious condition.
- Iatrogenic causes are significant contributors to this syndrome.
- Atropine is a common medication with anticholinergic properties.